Titleist Asset Management LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,076 shares of the healthcare conglomerate's stock after purchasing an additional 616 shares during the period. Titleist Asset Management LLC's holdings in UnitedHealth Group were worth $1,050,000 at the end of the most recent reporting period.
Other hedge funds also recently modified their holdings of the company. Geode Capital Management LLC grew its stake in UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after acquiring an additional 319,515 shares in the last quarter. Norges Bank purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $6,375,744,000. Franklin Resources Inc. lifted its position in UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock worth $4,514,178,000 after buying an additional 861,854 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of UnitedHealth Group by 0.5% in the fourth quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate's stock worth $4,012,218,000 after acquiring an additional 36,394 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in UnitedHealth Group by 3.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 6,223,331 shares of the healthcare conglomerate's stock valued at $3,148,134,000 after purchasing an additional 182,361 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Down 2.9 %
UNH opened at $524.94 on Monday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a market capitalization of $480.17 billion, a P/E ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm's fifty day moving average price is $509.24 and its two-hundred day moving average price is $541.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter last year, the company earned $5.83 earnings per share. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.
Insider Transactions at UnitedHealth Group
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.33% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on UNH shares. Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Truist Financial dropped their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. HSBC upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Barclays reduced their price target on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Finally, Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $629.32.
View Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report